Inanovate, Inc.
PrivateLast Round
VC Round
Jul 2, 2025
Total Funding Raised
$6.4M
Company Overview
Inanovate, Inc. operates in Healthcare & Life Sciences and is based in Sioux Falls, South Dakota. Its latest recorded funding round was a VC Round in July 2025.
Inanovate, Inc. is a biotechnology company that develops diagnostic tests for cancer and other diseases using its proprietary Bio-ID multiplexed protein quantification platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inanovate, Inc. Comparables
Compare Inanovate, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quansys Biosciences | 77% | |
| Thermo Fisher Scientific Inc. | 74% | |
| ProteoWise | 73% |
For institutional investors. Book with your work email.
Inanovate, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 2, 2025 | ||||
| VC Round | Nov 15, 2024 | ||||
| VC Round | Jun 12, 2024 | ||||
| Debt | Apr 27, 2020 | ||||
| Grant | Aug 21, 2019 | ||||
Series C | Apr 3, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Inanovate, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| South Dakota Equity Partners | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2025
$808K raised in a VC Round.
- Nov 15, 2024
$3.5M raised in a VC Round.
For institutional investors. Book with your work email.
Inanovate, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inanovate, Inc.'s valuation, stock price, and market status.
Is Inanovate, Inc. a public or private company?
Inanovate, Inc. is a private company.
What is the current stock price of Inanovate, Inc.?
Inanovate, Inc. is a private company, so its shares have no public market price. Caplight tracks Inanovate, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inanovate, Inc. worth (valuation)?
Valuation information for Inanovate, Inc. is not publicly available.
Can I buy Inanovate, Inc. stock?
Inanovate, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inanovate, Inc.'s last funding round?
Inanovate, Inc.'s most recent funding round was VC Round on July 2, 2025.
Who are the main investors in Inanovate, Inc.?
Key investors in Inanovate, Inc. include National Cancer Institute, South Dakota Equity Partners.
Will Inanovate, Inc. IPO soon?
No public IPO plans have been announced for Inanovate, Inc..
How can I track Inanovate, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Inanovate, Inc.'s shares on secondary markets.